Stage 4 Chronic Kidney Disease: Managing Complications and Preparing for Kidney Replacement Therapy

Stage 4 chronic kidney disease (CKD), defined by an estimated glomerular filtration rate (eGFR) of 15–29 mL/min/1.73 m², represents severe loss of kidney function. At this stage, proactive management focuses on three pillars: slowing disease progression, controlling complications, and preparing for kidney replacement therapy (KRT) well before it becomes urgent.

Key Complications at Stage 4

The kidneys' declining ability to filter waste, balance electrolytes, and produce hormones leads to a cascade of systemic issues. The table below summarizes the most common complications, their mechanisms, and standard management approaches.

ComplicationMechanismManagement
AnemiaReduced erythropoietin productionErythropoiesis-stimulating agents (ESAs), iron repletion (often IV), target hemoglobin 10–11 g/dL
Mineral & Bone Disorder (CKD-MBD)Elevated phosphate, low calcitriol, high PTH, low calciumPhosphate binders, vitamin D analogs, calcimimetics, dietary phosphate restriction
Metabolic AcidosisImpaired acid excretionSodium bicarbonate if serum bicarbonate <22 mEq/L
Fluid Overload / HypertensionReduced sodium excretionSalt restriction, loop diuretics, blood pressure target <130/80 mmHg
Cardiovascular DiseaseAccelerated atherosclerosis, left ventricular hypertrophyStatin therapy, SGLT2 inhibitor (if eGFR ≥20), aspirin if indicated
Malnutrition / Protein-Energy WastingAnorexia, inflammation, nutrient lossDietitian-guided nutrition, adequate protein (0.8 g/kg), oral supplements
Neuropathy / EncephalopathyUremic toxin accumulationDialysis planning; avoid nephrotoxins
HyperkalemiaReduced potassium excretionDietary potassium restriction, potassium binders (patiromer, sodium zirconium cyclosilicate), hold ACEi/ARB if severe

Treatment Goals

  • Slow progression: ACE inhibitor or ARB (if tolerated), SGLT2 inhibitor (dapagliflozin/empagliflozin approved down to eGFR 20), tight blood pressure and glycemic control, strict avoidance of nephrotoxins (NSAIDs, IV contrast, certain antibiotics).
  • Manage complications: Address each issue per the table above with regular monitoring.
  • Nutritional optimization: Plant-dominant, low-sodium diet with moderate protein (0.8 g/kg/day) and phosphate restriction under dietitian supervision.
  • Vaccinations: Stay current on hepatitis B, pneumococcal, COVID-19, influenza, and RSV vaccines (age-appropriate).

Kidney Replacement Therapy (KRT) Planning — Start Early

Initiating discussions about dialysis and transplant at Stage 4—ideally 12–18 months before anticipated need—leads to better outcomes, avoids emergency dialysis, and preserves patient autonomy.

1. Education & Modality Selection

Patients should explore all options with their care team. The table below outlines the major modalities.

ModalityProsConsBest For
Preemptive TransplantBest survival and quality of life; avoids dialysis entirelyDonor shortage; lifelong immunosuppression risksEligible candidates with a living donor
Peritoneal Dialysis (PD)Home-based, flexible schedule, preserves residual kidney function, continuous therapyInfection risk (peritonitis); requires abdominal catheter; not suitable for all anatomiesMotivated patients seeking independence
Home Hemodialysis (HHD)More frequent/longer sessions, better outcomes, home settingTraining burden; space requirements; care partner often neededMotivated, capable patients with support
In-Center HemodialysisProfessional staff; social interaction; no home equipmentFixed schedule, travel burden, "dialysis crash" symptoms, vascular access issuesPatients unable or unwilling to do home therapy
Conservative ManagementFocus on symptom control and quality of life without dialysisShorter survival; not appropriate for everyoneFrailty, advanced comorbidities, or patient choice

2. Vascular Access Preparation (If Hemodialysis Is Planned)

  • AV Fistula: Gold standard. Create 6–12 months before anticipated need to allow maturation.
  • AV Graft: Option if vessels are inadequate; shorter maturation time but higher infection/clotting risk.
  • Central Venous Catheter: Last resort only; high infection and thrombosis risk.

3. Advance Care Planning

  • Goals-of-care conversations with family and clinicians.
  • Complete advance directives and designate a healthcare proxy.
  • Integrate palliative care early for symptom management and support.

Multidisciplinary Care Team

Optimal Stage 4 care requires coordination among:

  • Nephrologist (quarterly visits minimum)
  • Renal dietitian (essential for nutrition management)
  • CKD educator/coordinator
  • Social worker (insurance, transplant evaluation, psychosocial support)
  • Pharmacist (medication reconciliation, renal dosing adjustments)
  • Vascular access surgeon (timely referral for fistula/graft)
  • Transplant center (early referral if candidate)

Patient Action Items

  1. Know your eGFR and track the trend.
  2. Bring an updated medication list to every visit.
  3. Follow your renal dietitian's guidance closely.
  4. Report new or worsening symptoms promptly.
  5. Complete transplant evaluation if eligible.
  6. Choose a dialysis modality before urgent need arises.
  7. Protect vascular access sites—no blood pressures or IVs on the fistula arm.

Prognosis: With optimal care, many patients remain in Stage 4 for years. Timely transition to KRT avoids emergency dialysis initiation, which is associated with worse outcomes and higher mortality.

Kidney Disease - Related Articles